DPG Mitgliedschaft
This block is broken or missing. You may be missing content or you might need to enable the original module.
Keyword: Astellas Pharma
News
30.10.2020
-
Japanese drugmaker Astellas Pharma has agreed to buy US bioelectronics startup Iota Biosciences. The move follows their R&D agreement signed in August 2019, under which...
News
16.08.2018
- Japan’s Astellas Pharma has acquired Cambridge, UK-based Quethera, a gene therapy company focused on developing novel treatments for eye disease, such as glaucoma. The acquisition...
News
28.06.2017
- The Association of the British Pharmaceutical Industry (ABPI) has suspended Astellas UK’s membership for a further 12 months from Jun. 24 because of several serious breaches of its...
Topstories
08.06.2015
- On June 2, The International Society for Pharmaceutical Engineering (ISPE) formally appreciated its 2015 Facility of the Year Awards (FOYA) category winners at a banquet in...
News
03.11.2014
- Dutch genetic testing specialist Qiagen has signed a master collaboration agreement with Astellas Pharma, a Japanese R&D-driven global pharmaceutical company, to develop and...
News
21.11.2013
- The U.S. Food and Drug Administration warned physicians on Wednesday that two chemicals used to conduct cardiovascular stress tests can cause heart attacks and death, and it...
News
18.07.2013
- China announced a nationwide crackdown on the sale of illegal medicine on Wednesday and said it would tighten industry regulation, piling pressure on a sector already reeling from...
News
19.04.2013
- Japan's Astellas Pharma and Britain's GlaxoSmithKline are competing to develop a new kind of medicine that boosts production of red blood cells by making the body think it is at...
Ehrenamtliches Engagement
This block is broken or missing. You may be missing content or you might need to enable the original module.
